Delayed Clinical Response in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept

Marieke H. Otten, Femke H. M. Prince, Marinka Twilt, Marion A. J. van Rossum, Wineke Armbrust, Esther P. A. H. Hoppenreijs, Sylvia Kamphuis, Yvonne Koopman-Keemink, Nico M. Wulffraat, Simone L. Gorter, Rebecca ten Cate, Lisette W. A. van Suijlekom-Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)665-667
JournalJournal of Rheumatology
Volume37
Issue number3
DOIs
Publication statusPublished - Mar 2010

Keywords

  • JUVENILE IDIOPATHIC ARTHRITIS
  • ANTIRHEUMATIC AGENTS
  • TUMOR NECROSIS FACTOR-alpha
  • DRUG ADMINISTRATION SCHEDULE
  • TREATMENT OUTCOME
  • ARTHRITIS

Cite this

Otten, M. H., Prince, F. H. M., Twilt, M., van Rossum, M. A. J., Armbrust, W., Hoppenreijs, E. P. A. H., Kamphuis, S., Koopman-Keemink, Y., Wulffraat, N. M., Gorter, S. L., ten Cate, R., & van Suijlekom-Smit, L. W. A. (2010). Delayed Clinical Response in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept. Journal of Rheumatology, 37(3), 665-667. https://doi.org/10.3899/jrheum.090550